Abstract:Nitrogen-based heterocycles such as pyrazole, imidazole, 1,2,4-triazole, benzimidazole, and benzotriazole substituted fused pyran derivatives (6a-e, 8a-e, 10a-e, 12a-e & 14a-e) have been synthesized and tested for their in vitro anticancer efficacies against MCF7, A549 and HCT116 cancer cell lines. Among the compounds, 6e, 12a, 14b against MCF7, 12a, 12c, 12d, 14b-d against A549, and 8c, 8e against HCT116 displayed promising activity with the IC50 values in the range of 0.23 ± 0.12 to 32.14 ± 0.83 M. Among them, 6e, 14b, and 8c were identified as the most potent against MCF7, A549, and HCT116 with IC50 values of 12.46 ± 2.72 M, 0.23 ± 0.12 M, and 7.58 ± 1.01 M, respectively. Except for 12a and 14b, remaining all active compounds exhibited selective inhibitory activity on different cancer cell types. It has been identified that these compounds can change cellular and nuclear morphology and inhibit colony formation in the tested cancer cells. They also remarkably block/inhibit the cell cycle progression of cancer cells at various phases. DNA damage analysis and apoptosis studies revealed that these compounds have the potential to induce DNA double-strand breaks and apoptosis. In a time when breakthroughs in cancer treatment are fervently sought, the emergence of fused pyran derivatives as potent anticancer agents is of immense value. As we delve deeper into their mechanisms and optimize their properties, these compounds hold promise as a significant step forward in the ongoing battle against cancer. In silico ADMET properties of the potent compounds were assessed, revealing that all the compounds exhibited favorable pharmacokinetic and toxicological properties. Thus, this study not only contributes to the scientific understanding of heterocycle-based compounds but also resonates with the pressing need for innovative solutions to address the global challenge of cancer.

Synthesis And Biological Evaluation Of Dimeric Furanoid Macroheterocycles: Discovery Of New Anticancer Agents

Synthesis and Biological Evaluation of Novel Furopyridone Derivatives as Potent Cytotoxic Agents against Esophageal Cancer

Design, synthesis and antitumor efficacy evaluation of a series of novel β-elemene-based macrocycles

Synthesis and cytotoxicity evaluation of novel 1,8-acridinedione derivatives bearing phthalimide moiety as potential antitumor agents

Synthesis and Biological Evaluation of a Novel Class of Coumarin Derivatives.

Discovery of Novel Heteroarylmethylcarbamodithioates As Potent Anticancer Agents: Synthesis, Structure-Activity Relationship Analysis and Biological Evaluation.

Synthesis of New Chromen-5-one Derivatives from Dimedone and their Antiproliferative Evaluations against Selected Cancer Cell Lines Together with Hepatocellular Carcinoma and Cervical Carcinoma

Novel Fused Pyran Derivatives Induce Apoptosis and Target Cell Cycle Progression in Anticancer Efficacy against Multiple Cell Lines

Design, Synthesis, and Biological Evaluation of Novel Γ-Carboline Ketones As Anticancer Agents

Synthesis of novel cytotoxic tetracyclic acridone derivatives and study of their molecular docking, ADMET, QSAR, bioactivity and protein binding properties

Synthesis, characterization and bioactivity of new pyridine-2(H)-one, nicotinonitrile, and furo[2,3-b]pyridine derivatives

Nitrogen-containing Fused Heterocycles: Organic Synthesis and Applications as Potential Anticancer Agents

Synthesis and in Vitro Antitumor Activity of Substituted Anthracene‐1,4‐diones.

Selective and effective anticancer agents: Synthesis, biological evaluation and structure–activity relationships of novel carbazole derivatives

Discovery of pyran annulated heterocyclic scaffolds linked to carboxamide fragments: Anticancer evaluation, topoisomerase I/II, tyrosine kinase receptor inhibition and molecular docking studies

Synthesis, crystal structure and evaluation of anticancer activities of some novel heterocyclic compounds based on thymol

Novel Amide Functionalized Trifluoromethyl thieno[2,3-b]pyridine Derivatives: Anti-cancer Activity and Molecular Docking Studies

Heteroaromatization of Coumarin Part I: Design, Synthesis, Reactions, Antitumor Activities of Novel Pyridine and Naphthyridine Derivatives

Design, Synthesis and Biological Evaluation of Nitrogen-Containing Macrocyclic Bisbibenzyl Derivatives As Potent Anticancer Agents by Targeting the Lysosome.

Design, Synthesis and Characterization of novel 1,5- and 2,5-coumarin-4-yl-methyl regioisomers of 5-pyrazol-3-yl-tetrazoles as promising anticancer and antifungal agents

FDA-approved pyrimidine-fused bicyclic heterocycles for cancer therapy: Synthesis and clinical application